Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients

Ohara, Toshiaki; Ikeda, Hiroshi; Sugitani, Yoshiki; Suito, Hiroshi; Huynh, Viet Quang Huy; Kinomura, Masaru; Haraguchi, Soichiro; Sakurama, Kazufumi

doi:10.7150/ijms.53298



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2021; 18(8):1831-1839. doi:10.7150/ijms.53298 This issue Cite

Research Paper

Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients

Toshiaki Ohara^1,2✉, Hiroshi Ikeda³, Yoshiki Sugitani⁴, Hiroshi Suito⁴, Viet Quang Huy Huynh⁴, Masaru Kinomura⁵, Soichiro Haraguchi⁶, Kazufumi Sakurama^2,7

1. Department of Pathology & Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
2. Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
3. Department of Internal Medicine, Shigei Medical Research Hospital, Okayama, Japan.
4. Advanced Institute for Materials Research, Tohoku University, Miyagi, Japan.
5. Division of Hemodialysis and Apheresis, Okayama University Hospital, Okayama, Japan.
6. Kobayashi Medicine Clinic, Okayama, Japan.
7. Department of Dialysis Access Center, Shigei Medical Research Hospital, Okayama, Japan.

Citation:

Ohara T, Ikeda H, Sugitani Y, Suito H, Huynh VQH, Kinomura M, Haraguchi S, Sakurama K. Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients. Int J Med Sci 2021; 18(8):1831-1839. doi:10.7150/ijms.53298. https://www.medsci.org/v18p1831.htm

Other styles

Abstract

Anemia, for which erythropoiesis-stimulating agents (ESAs) and iron supplements (ISs) are used as preventive measures, presents important difficulties for hemodialysis patients. Nevertheless, the number of physicians able to manage such medications appropriately is not keeping pace with the rapid increase of hemodialysis patients. Moreover, the high cost of ESAs imposes heavy burdens on medical insurance systems. An artificial-intelligence-supported anemia control system (AISACS) trained using administration direction data from experienced physicians has been developed by the authors. For the system, appropriate data selection and rectification techniques play important roles. Decision making related to ESAs poses a multi-class classification problem for which a two-step classification technique is introduced. Several validations have demonstrated that AISACS exhibits high performance with correct classification rates of 72%-87% and clinically appropriate classification rates of 92%-98%.

Keywords: anemia, artificial intelligence, chronic kidney disease, erythropoiesis-stimulating agents, hemodialysis, iron

Citation styles

APA

Ohara, T., Ikeda, H., Sugitani, Y., Suito, H., Huynh, V.Q.H., Kinomura, M., Haraguchi, S., Sakurama, K. (2021). Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients. International Journal of Medical Sciences, 18(8), 1831-1839. https://doi.org/10.7150/ijms.53298.

ACS

Ohara, T.; Ikeda, H.; Sugitani, Y.; Suito, H.; Huynh, V.Q.H.; Kinomura, M.; Haraguchi, S.; Sakurama, K. Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients. Int. J. Med. Sci. 2021, 18 (8), 1831-1839. DOI: 10.7150/ijms.53298.

NLM

CSE

Ohara T, Ikeda H, Sugitani Y, Suito H, Huynh VQH, Kinomura M, Haraguchi S, Sakurama K. 2021. Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients. Int J Med Sci. 18(8):1831-1839.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.